Search
for
Sort by
Research 30 of 1000+
- Alopecia universalis following interferon alfa-2b and ribavirin treatment for hepatitis C.
- Follow‐up of Adverse Drug Reactions from Peginterferon alfa‐2b—Ribavirin Therapy
- Cutaneous necrosis after injection of polyethylene glycol–modified interferon alfa
- High dose interferon treatment in chronic hepatitis C.
- Segmental Vitiligo and Hair Curling After Interferon α and Ribavirin Treatment for Hepatitis C
- Psoriasis and Hepatitis C: Improvement with Interferon
- Straight hair associated with interferon-alfa plus ribavirin in hepatitis C infection
- Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection
- Telogen Effluvium due to Recombinant Interferon α-2b
- Interferon in the treatment of cutaneous T-cell lymphoma
- Resolution of advanced conjunctival squamous cell carcinoma with cemiplimab immunotherapy, IFNα-2b, and retinoic acid treatment over 2 years of follow-up
- Dermatologic therapy: December 1986 to December 1987
- Aldesleukin
- Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report
- Bullous Lesions at Polyethylene Glycol Interferon-alpha-2a Inoculation Site in a Hepatitis C Virus-infected Subject
- Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area
- Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C
- INTERFERONS IN DERMATOLOGY
- Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Immunomodulators in the treatment of cutaneous lymphoma
- Frontal Fibrosing Alopecia During Treatment of Chronic Hepatitis C: A Case Report
- Current management strategies for cutaneous T-cell lymphoma
- A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin
- Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
- Pharmacotherapy for Keloids and Hypertrophic Scars
- CUTANEOUS T-CELL LYMPHOMA
- Farmácia dos Clérigos - Porto e nos Serviços Farmacêuticos da University College Hospital - Londres, Reino Unido, ao abrigo do programa Erasmus+
- Farmácia Aliança - Maia
- Trichodysplasia of immunosuppression treated with oral valganciclovir